Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'- arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma

Anti-Cancer Drugs

Volumn 8, Issue 5, 1997, Pages 445-453

  Lindemalm, Synnöve ^a   Albertioni, Freidoun ^a   Liliemark, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

2 chloro 2' deoxyadenosine; 2 Chloro 2' arabino fluoro 2' deoxy adenosine; Chloroadenosine; Reverse phase HPLC; Stability; Storage

Indexed keywords

2 CHLORO 2' ARABINOFLUORO 2' DEOXYADENOSINE; 2 CHLOROADENINE; ADENINE DERIVATIVE; ADENOSINE DERIVATIVE; ANTINEOPLASTIC AGENT; CLADRIBINE; DRUG METABOLITE; PURINE NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; DRUG STORAGE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030757255     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199706000-00005     Document Type: Article

References (17)

1. Christensen LF, Broom AD, Robins MJ, Bloch A. Synthesis and biological activity of selected 2,6-disubstituted-(2-deoxy- and D-erythro-pentofuranosyl)purines. J Med Chem 1972; 15: 735-9.
2. Bryson HM, Sorkin EM. Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies. Drugs 1993; 46: 872-94.
3. Carson DA, Wasson DB, Taetle R, Yu A. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 1983; 62: 737-43.
4. Carson DA, Wasson DB, Esparza LM, Carrera CJ, Kipps TJ, Cottam HB. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine. Proc Natl Acad Sci USA 1992; 89: 2970-4.
5. Wang L, Karlsson A, Arner ES, Eriksson S. Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. J Biol Chem 1993; 268: 22847-52.
6. Seto S, Carrera CJ, Kubota M, Wasson DB, Carson DA. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lympocytes. J Clin Invest 1985; 75: 377-83.
7. Juliusson G, Heldal D, Hippe E, et al. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. J Clin Oncol 1995; 13: 989-95.
8. Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990; 322: 1117-21.
9. Sipe JC, Romine JS, Koziol JA, McMillan R, Zyroff J, Beutler E. Cladribine in treatment of chronic progressive multiple sclerosis. Lancet 1994; 344: 9-13.
10. Sanatana V, Mirro J, Kearns C, Schell M, Crom W, Blakley R. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remissions in relapsed acute myeloid leukemia. J Clin Oncol 1992; 10: 364-70.
11. Gajewska M, Pawinski T, Dzierzgowska-Szmidt A, Kazimierczuk Z. Spectrofluorimetric determination of 2-chloro-2′-deoxyadenosine (Cladribine) in human plasma by photochemical reaction and chloroacetaldehyde derivatization. Pharmazie 1995; 50: 459-60.
12. Albertioni F, Pettersson B, Reichelova V, Juliusson G, Liliemark J. Analysis of 2-chloro-2′-deoxyadenosine in human blood plasma and urine by high-performance liquid chromatography using solid-phase extraction. Ther Drug Monit 1994; 16: 413-8.
13. Liliemark J, Pettersson B, Juliusson G. Determination of 2-chloro-2′-deoxyadenosine in human plasma. Biomed Chromatogr 1991; 5: 262-4.
14. Liliemark J, Albertioni F, Hassan M, Juliusson G. On the bioavailability of oral and subcutaneous 2-chloro-2′-deoxyadenosine in humans: alternative routes of administration. J Clin Oncol 1992; 10: 1514-8.
15. Albertioni F, Juliusson G, Liliemark J. On the bioavailability of 2-chloro-2′-deoxyadenosine (CdA). The influence of food and omeprazole. Eur J Clin Pharmacol 1993; 44: 579-82.
16. Saven A, Cheung WK, Smith I, et al. Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy. J Clin Oncol 1996; 14: 978-83.
17. Ehrnebo M, Odar-Cederlof I. Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: effect of salicylic acid, temperature and total drug concentration. Eur J Clin Pharmacol 1977; 11: 37-42.